Growth Metrics

Pulmonx (LUNG) EBIT Margin (2019 - 2025)

Pulmonx (LUNG) reported EBIT Margin of 66.94% for Q3 2025, up 237.0% year-over-year from 19.86% in Q3 2024, and down 7.88% on a QoQ basis from 62.05% in Q2 2025.

Pulmonx (LUNG) has 7 years of EBIT Margin data on file, last reported at 66.94% in Q3 2025.

  • Quarterly EBIT Margin rose 237.0% year-over-year to 66.94% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 62.38% (up 1102.0% YoY) and the FY2024 annual result came in at 68.87%, up 2132.0% from the prior year.
  • EBIT Margin slipped to 66.94% in Q3 2025 per LUNG's latest filing, from 62.05% in the prior quarter.
  • Across five years, EBIT Margin topped out at 56.46% in Q4 2024 and bottomed at 145.28% in Q1 2022.
  • The 5-year median for EBIT Margin is 85.9% (2023), against an average of 88.82%.
  • Peak annual rise in EBIT Margin reached 20988 bps in 2021, while the deepest fall reached 6433 bps in 2021.
  • Tracing LUNG's EBIT Margin over 5 years: stood at 90.21% in 2021, then retreated by 5 bps to 94.83% in 2022, then increased by 24 bps to 72.2% in 2023, then gained by 22 bps to 56.46% in 2024, then fell by 19 bps to 66.94% in 2025.
  • Per Business Quant, the three latest LUNG EBIT Margin figures stand at 66.94% (Q3 2025), 62.05% (Q2 2025), and 64.62% (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Pulmonx 67.30 Mn -2.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -66.94%
Jun 30, 2025 -62.05%
Mar 31, 2025 -64.62%
Dec 31, 2024 -56.46%
Sep 30, 2024 -69.30%
Jun 30, 2024 -75.17%
Mar 31, 2024 -77.10%
Dec 31, 2023 -72.20%
Sep 30, 2023 -85.90%
Jun 30, 2023 -95.61%
Mar 31, 2023 -112.83%
Dec 31, 2022 -94.83%
Sep 30, 2022 -103.18%
Jun 30, 2022 -103.30%
Mar 31, 2022 -145.28%
Dec 31, 2021 -90.21%
Sep 30, 2021 -73.61%
Jun 30, 2021 -103.93%
Mar 31, 2021 -135.16%
Dec 31, 2020 -95.16%
Sep 30, 2020 -50.40%
Jun 30, 2020 -313.80%
Mar 31, 2020 -70.83%
Dec 31, 2019 -41.46%
Sep 30, 2019 -39.69%